Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
The New England Journal of Medicine
|
March 23, 2026
Facial Synkinesis
Ranjan Gupta, Rudra Prosad Goswami
Scientific Reports
|
January 29, 2021
Network theoretic analysis of JAK/STAT pathway and extrapolation to drugs and viruses including COVID-19
Arindam Banerjee, Rudra Prosad Goswami, Moumita Chatterjee
International Journal of Rheumatic Diseases
|
November 18, 2024
Defining Objective BASDAI Cut-Offs for Disease Activity States and Improvement Scores in Axial Spondyloarthritis: A Multicentric Collaboration
Rudra Prosad Goswami, Moumita Chatterjee, Shyamashis Das
Journal of Medical Virology
|
February 13, 2021
Endemic infections, vaccinations, and variability of SARS-COV2 worldwide epidemiology: A cross-sectional study
Rudra Prosad Goswami, Bhaswati Ganguli, Moumita Chatterjee
Arthritis & Rheumatology (Hoboken, N.J.)
|
June 15, 2026
Knot of Henry Tenosynovitis Mimicking Enthesitis in Spondyloarthritis
Rahul Kumar, Niket Verma, Rudra Prosad Goswami
Indian Journal of Medical Sciences
|
December 12, 2013
Bedside utility of clinical scoring systems in classifying stroke
Rudra Prosad Goswami, Partha Sarathi Karmakar, Alakendu Ghosh
Rheumatology (Oxford, England)
|
August 29, 2015
Ultrasound is a useful adjunct in diagnosis of eosinophilic fasciitis
Sumantro Mondal, Rudra Prosad Goswami, Debanjali Sinha, et al.
European Journal of Gastroenterology & Hepatology
|
December 6, 2011
Absolute CD4 counts in monoinfected chronic hepatitis B patients in the advanced immune-active stage
Rama Prosad Goswami, Rudra Prosad Goswami, Yogiraj Ray, et al.
Clinical Rheumatology
|
December 8, 2018
Steroid-free remission in lupus: myth or reality; an observational study from a tertiary referral centre
Rudra Prosad Goswami, Hiramanik Sit, Parasar Ghosh, et al.
Rheumatology (Oxford, England)
|
April 2, 2019
Comment on: Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial: reply
Geetabali Sircar, Rudra Prosad Goswami, Dipankar Sircar, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
The New England Journal of Medicine
|
March 23, 2026
Facial Synkinesis
Ranjan Gupta, Rudra Prosad Goswami
Scientific Reports
|
January 29, 2021
Network theoretic analysis of JAK/STAT pathway and extrapolation to drugs and viruses including COVID-19
Arindam Banerjee, Rudra Prosad Goswami, Moumita Chatterjee
International Journal of Rheumatic Diseases
|
November 18, 2024
Defining Objective BASDAI Cut-Offs for Disease Activity States and Improvement Scores in Axial Spondyloarthritis: A Multicentric Collaboration
Rudra Prosad Goswami, Moumita Chatterjee, Shyamashis Das
Journal of Medical Virology
|
February 13, 2021
Endemic infections, vaccinations, and variability of SARS-COV2 worldwide epidemiology: A cross-sectional study
Rudra Prosad Goswami, Bhaswati Ganguli, Moumita Chatterjee
Arthritis & Rheumatology (Hoboken, N.J.)
|
June 15, 2026
Knot of Henry Tenosynovitis Mimicking Enthesitis in Spondyloarthritis
Rahul Kumar, Niket Verma, Rudra Prosad Goswami
Indian Journal of Medical Sciences
|
December 12, 2013
Bedside utility of clinical scoring systems in classifying stroke
Rudra Prosad Goswami, Partha Sarathi Karmakar, Alakendu Ghosh
Rheumatology (Oxford, England)
|
August 29, 2015
Ultrasound is a useful adjunct in diagnosis of eosinophilic fasciitis
Sumantro Mondal, Rudra Prosad Goswami, Debanjali Sinha, et al.
European Journal of Gastroenterology & Hepatology
|
December 6, 2011
Absolute CD4 counts in monoinfected chronic hepatitis B patients in the advanced immune-active stage
Rama Prosad Goswami, Rudra Prosad Goswami, Yogiraj Ray, et al.
Clinical Rheumatology
|
December 8, 2018
Steroid-free remission in lupus: myth or reality; an observational study from a tertiary referral centre
Rudra Prosad Goswami, Hiramanik Sit, Parasar Ghosh, et al.
Rheumatology (Oxford, England)
|
April 2, 2019
Comment on: Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial: reply
Geetabali Sircar, Rudra Prosad Goswami, Dipankar Sircar, et al.
Page
of 4